Articles

1. Quality of life in Prolactinoma: A systematic review

   • Mendel Castle-Kirszbaum
   • Nienke Biermasz
   • Tony Goldschlager

   OriginalPaper Open access 24 April 2024

2. Changes in multi-modality management of acromegaly in a tertiary centre over 2 decades

   • V. Amodru
   • N. Sahakian
   • F. Castinetti

   OriginalPaper 23 March 2024

   

3. Prolactin-secreting tumors, dopamine agonists and pregnancy: a longitudinal experience of a tertiary neuroendocrine center

   • Nunzia Prencipe
   • Chiara Bona
   • Silvia Grottoli

   OriginalPaper Open access 18 March 2024

   

4. Pituitary tumours without distinct lineage differentiation express stem cell marker SOX2

   • Nèle F. Lenders
   • Tanya J. Thompson
   • Ann I. McCormack

   OriginalPaper Open access 14 March 2024

   

5. Correction: Impulse control disorders in patients with dopamine agonist-treated pituitary adenomas: a cross-sectional multicenter study

   • Mussa H. Almalki
   • Moayad A. Alsuraikh
   • Aishah Ekhzaimy

   Correction 13 March 2024 Pages: 238 - 238

6. Glucose intolerance in acromegaly is driven by low insulin secretion; results from an intravenous glucose tolerance test

   • Laura Georgiana Zaifu
   • Dan Alexandru Niculescu
   • Catalina Poiana

   OriginalPaper 21 February 2024 Pages: 178 - 186

   

7. Elevated risk of recurrence and retreatment for silent pituitary adenomas

   • Saksham Gupta
   • Samantha E. Hoffman
   • Edward R. Laws

   OriginalPaper 12 February 2024 Pages: 204 - 212

   

8. Impulse control disorders in patients with dopamine agonist-treated pituitary adenomas: a cross-sectional multicenter study

   • Mussa H. Almalki
   • Moayad A. Alsuraikh
   • Aishah Ekhzaimy

   OriginalPaper 12 February 2024 Pages: 197 - 203

9. Different patient versus provider perspectives on living with Cushing’s disease

   • Amanda Halstrom
   • I.-Hsin Lin
   • Eliza B. Geer

   OriginalPaper Open access 05 February 2024 Pages: 141 - 150

   

10. Pituitary hypophysitis in granulomatosis with polyangiitis (GPA): a case series

    • Majid Alameri
    • Abdulla Alnuaimi
    • Florian Wernig

    OriginalPaper Open access 31 January 2024 Pages: 230 - 237

    

11. Successful treatment of medically and surgically refractory lymphocytic hypophysitis with fractionated stereotactic radiotherapy: a single-center experience and systematic literature review

    • Mehdi Khaleghi
    • Guilherme Finger
    • Daniel Prevedello

    OriginalPaper 25 January 2024 Pages: 213 - 229

    

12. Diffusion-weighted imaging does not seem to be a predictor of consistency in pituitary adenomas

    • Monique Alvares Barbosa
    • Eduardo Giardini Rodovalhe Pereira
    • Monica R. Gadelha

    OriginalPaper 25 January 2024 Pages: 187 - 196

    

13. Basal cortisol in relation to metyrapone confirmation in predicting adrenal insufficiency after pituitary surgery

    • Pieter E. Huisman
    • Sarah E. Siegelaar
    • Eveline Bruinstroop

    OriginalPaper Open access 19 January 2024 Pages: 151 - 159

    

14. A medical chart audit to assess endocrinologist perceptions of the burden of endogenous Cushing’s syndrome

    • Gabrielle Page-Wilson
    • Bhagyashree Oak
    • Eliza B. Geer

    ReviewPaper Open access 08 January 2024 Pages: 129 - 140

    

15. Current status of artificial intelligence technologies in pituitary adenoma surgery: a scoping review

    • Seyed Farzad Maroufi
    • Yücel Doğruel
    • Paolo Palmisciano

    ReviewPaper 06 January 2024 Pages: 91 - 128

    

16. Prediction of adrenal insufficiency after pituitary surgery: a retrospective study using beckman access cortisol assay

    • Maria Francesca Birtolo
    • Emma Giannini
    • Andrea G. Lania

    OriginalPaper 03 January 2024 Pages: 160 - 168

    

17. Pituitary: hic manebimus optime

    • Andrea Giustina

    Editorial 03 January 2024 Pages: 3 - 6

18. A fond farewell

    • Shlomo Melmed

    Editorial 03 January 2024 Pages: 1 - 2

19. Correction: incidence of postoperative hyponatremia after endoscopic endonasal pituitary transposition for skull base pathologies

    • Francesca Galbiati
    • Sharini Venugopal
    • Hussain Mahmud

    Correction 30 December 2023 Pages: 89 - 90

    

20. Acromegaly increases depressive symptoms and reduces quality of life of cohabitants

    • Serhat Uysal
    • Cem Sulu
    • Pinar Kadioglu

    OriginalPaper 30 December 2023 Pages: 169 - 177

    

21. Pituitary apoplexy score, toward standardized decision-making: a descriptive study

    • Henri Salle
    • Mathilde Cane
    • Laurence Salle

    OriginalPaper 27 December 2023 Pages: 77 - 87

    

22. Idiopathic isolated adrenocorticotropic hormone deficiency: a systematic review of a heterogeneous and underreported disease

    • E. Van Mieghem
    • C. De Block
    • C. De Herdt

    ReviewPaper 27 December 2023 Pages: 23 - 32

    

23. Cabergoline treatment for surgery-naïve non-functioning pituitary macroadenomas

    • Irit Ayalon-Dangur
    • Adi Turjeman
    • Ilan Shimon

    OriginalPaper 08 December 2023 Pages: 52 - 60

    

24. The prevalence and associated risk factors of detectable renal morphological abnormalities in acromegaly

    • Hayri Bostan
    • Muhammed Kizilgul
    • Erman Cakal

    OriginalPaper 08 December 2023 Pages: 44 - 51

    

25. Correction: consensus on criteria for acromegaly diagnosis and remission

    • Andrea Giustina
    • Nienke Biermasz
    • Acromegaly Consensus Group

    Correction Open access 06 December 2023 Pages: 88 - 88

26. Incidence of postoperative hyponatremia after endoscopic endonasal pituitary transposition for skull base pathologies

    • Francesca Galbiati
    • Sharini Venugopal
    • Hussain Mahmud

    OriginalPaper 25 November 2023 Pages: 70 - 76

    

27. Newer parameters of the octreotide test in patients with acromegaly

    • Shin Urai
    • Masaaki Yamamoto
    • Wataru Ogawa

    OriginalPaper 24 November 2023 Pages: 33 - 43

    

28. Symptoms and steroid dose adjustments following the Covid-19 vaccine in patients with adrenal insufficiency

    • David S. McLaren
    • Grace Crowe
    • Robert D. Murray

    OriginalPaper 17 November 2023 Pages: 61 - 69

29. Consensus on criteria for acromegaly diagnosis and remission

    • Andrea Giustina
    • Nienke Biermasz
    • Acromegaly Consensus Group

    OriginalPaper Open access 03 November 2023 Pages: 7 - 22

30. Assessment of forearm muscles with ultrasound shear wave elastography in patients with acromegaly

    • Meric Coskun
    • Halit Nahit Sendur
    • Fusun Balos Toruner

    OriginalPaper 30 October 2023 Pages: 716 - 724

    

31. Metastases to the pituitary gland: insights from the German pituitary tumor registry

    • Linus Haberbosch
    • Simone Schmid
    • Christian J. Strasburger

    OriginalPaper Open access 30 October 2023 Pages: 708 - 715

    

32. Correction: Care trajectories of surgically treated patients with a prolactinoma: why did they opt for surgery?

    • Victoria R. van Trigt
    • Ingrid M. Zandbergen
    • Nienke R. Biermasz

    Correction Open access 28 October 2023 Pages: 725 - 728

    

33. Endoscopic endonasal marsupialization of rathke cleft cysts: clinical outcomes and risk factors analysis of visual impairment, pituitary dysfunction, and CSF leak

    • Mohammad Bilal Alsavaf
    • Kyle C. Wu
    • Daniel M. Prevedello

    OriginalPaper 25 October 2023 Pages: 696 - 707

    

34. The impact of facility type and volume on treatment and overall survival in craniopharyngioma

    • Benjamin F. Bitner
    • Derek H. Liu
    • Edward C. Kuan

    OriginalPaper 17 October 2023 Pages: 686 - 695

    

35. Clinical characteristics and therapeutic outcomes of acromegalic patients with giant growth hormone-secreting pituitary adenomas: a single-center study of 67 cases

    • Meiping Chen
    • Lian Duan
    • Huijuan Zhu

    OriginalPaper 17 October 2023 Pages: 675 - 685

    

36. Reported baseline variables in transsphenoidal surgery for pituitary adenoma over a 30 year period: a systematic review

    • Hugo Layard Horsfall
    • Ryan T. S. Loh
    • Angelos G. Kolias

    OriginalPaper Open access 16 October 2023 Pages: 645 - 652

    

37. Growth hormone insensitivity and adipose tissue: tissue morphology and transcriptome analyses in pigs and humans

    • Jonathan A. Young
    • Arne Hinrichs
    • Darlene E. Berryman

    OriginalPaper 25 September 2023 Pages: 660 - 674

    

38. Clinical and prognostic significance of granulation patterns in somatotroph adenomas/tumors of the pituitary: a meta-analysis

    • Huy Gia Vuong
    • Ian F. Dunn

    ReviewPaper 21 September 2023 Pages: 653 - 659

    

39. Anterior-posterior diameter is a key driver of resectability and complications for pituitary adenomas with suprasellar extension in endoscopic transsphenoidal surgery

    • Jung Park
    • Danielle Golub
    • Amir R. Dehdashti

    OriginalPaper 15 September 2023 Pages: 629 - 641

    

40. Pituitary metastases: a case series and scoping review

    • Kaiyun Yang
    • Sabrina L. Begley
    • Paul N. Kongkham

    OriginalPaper 12 September 2023 Pages: 538 - 550

    

41. Clinico-radiological correlation of pituitary stalk interruption syndrome in children with growth hormone deficiency

    • Subbiah Sridhar
    • Bhagadurshah Rameez Raja
    • Vasanthiy Natarajan

    OriginalPaper 11 September 2023 Pages: 622 - 628

    

42. Care trajectories of surgically treated patients with a prolactinoma: why did they opt for surgery?

    • Victoria R. van Trigt
    • Ingrid M. Zandbergen
    • Nienke R. Biermasz

    OriginalPaper Open access 10 September 2023 Pages: 611 - 621

    

43. Pituitary Tumor Centers of Excellence (PTCOE) should now include neuro-oncologic input

    • E. Jouanneau
    • F Calvanese
    • G. Raverot

    Letter 07 September 2023 Pages: 642 - 643

44. Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas

    • Tomonori Sekizaki
    • Hiraku Kameda
    • Tatsuya Atsumi

    OriginalPaper 29 August 2023 Pages: 597 - 610

    

45. Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers

    • A. Giustina
    • M. M. Uygur
    • F. F. Casanueva

    OriginalPaper Open access 28 August 2023 Pages: 583 - 596

    

46. Giant prolactinomas, a detailed analysis of 196 adult cases

    • Billion Lisa
    • Verleye Arno
    • De Herdt Carlien

    ReviewPaper 07 August 2023 Pages: 529 - 537

    

47. Changing presentation of acromegaly in half a century: a single-center experience

    • Ahmet Numan Demir
    • Cem Sulu
    • Pinar Kadioglu

    OriginalPaper 31 July 2023 Pages: 573 - 582

    

48. Metastatic pituitary tumors: an institutional case series

    • Alexander G. Yearley
    • Eric J. Chalif
    • Edward R. Laws

    OriginalPaper 31 July 2023 Pages: 561 - 572

    

49. Complications and mortality of Cushing’s disease: report on data collected over a 20-year period at a referral centre

    • Alessandro Mondin
    • Filippo Ceccato
    • Mattia Barbot

    OriginalPaper Open access 26 July 2023 Pages: 551 - 560

    

50. The efficacy of a visiting surgical service versus that of a hospital-based surgical service in providing endoscopic endonasal surgery to remove nonfunctioning pituitary adenomas in rural communities

    • Toshihiro Ogiwara
    • Satoshi Kitamura
    • Tetsuyoshi Horiuchi

    OriginalPaper 21 July 2023 Pages: 521 - 528